pharma news today glp-1 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 How Pharmacy Plans Are Managing

the American Diabetes Association recommends reassessing A1C about every 3 months after therapy changes

En un contexto en el que sabe que no solo ha entrado en desabastecimiento los frmacos anlogos de la GLP-1 (esta es la lista de todos los medicamentos que se encuentran en situacin de desabastecimiento temporal), Morales explica otra de las posibles razones: En Estados Unidos el problema de la obesidad es muy grande, por lo que las fbricas no han sido capaces de dar respuesta a la demanda tan grande y creciente que los propios laboratorios no han sido capaces de afrontarlo

Employee Sentiment and Retention Risks A recent Employee Benefit Research Institute (EBRI) study found that 64% of employees believe GLP1s should be included in their health plan coverage, yet nearly half of respondents were unsure if their current plan provided access

Acknowledging patients' concerns and discussing their issues should help them know that they have been heard, and it is helpful in breaking down barriers